A Single-center Pilot Study Evaluating a Preemptive Short Course of Glecaprevir/Pibrentasvir in Hepatitis C Positive to Negative Kidney Transplantation
EARLY_PHASE1
The purpose of this research study is to evaluate the feasibility of a 2 we...
Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6
N/A
This multi-center, post-marketing, observational study evaluates the real w...
Status
Completed
Location
Abbvie Japan /ID# 161985
Start Date
2017-12-27
Trial ID
NCT03341871
A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection
PHASE3
This was a Phase 3, open-label, multicenter study to evaluate the efficacy ...
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
PHASE3
The purpose of this study is to assess the efficacy and safety of ABT-493/A...